Ravidasvir
From Infogalactic: the planetary knowledge core
Ravidasvir (PPI-668) is an NS5A inhibitor in clinical trials for chronic hepatitis C Genotype-4.[1]
Clinical trial results were announced in Nov 2015.[2]
References
<templatestyles src="Asbox/styles.css"></templatestyles>